<DOC>
	<DOCNO>NCT00936728</DOCNO>
	<brief_summary>RATIONALE : It yet know whether white wine effective nutritional supplement improve appetite . PURPOSE : This randomized clinical trial study white wine see well work compare nutritional supplement improve appetite patient cancer</brief_summary>
	<brief_title>White Wine Nutritional Supplement Improving Appetite Patients With Cancer</brief_title>
	<detailed_description>OBJECTIVES : I . To compare white wine ( Arm A ) non-wine nutritional supplement ( Arm B ) treatment cancer-associated anorexia . II . To evaluate side effect profile white wine ( Arm A ) . OUTLINE : Patients stratify accord primary malignant disease ( lung vs gastrointestinal v [ specify ] ) , severity weight loss ( exclude peri-operative weight loss ) within past 2 month ( &lt; 4.6 kg [ &lt; 10 lb ] v &gt; = 4.6 kg [ &gt; = 10 lbs ] ) , age ( &lt; 50 year vs &gt; = 50 year ) , plan concurrent chemotherapy radiation ( yes v ) . Patients randomize 1 2 arm . ARM A : Patients consume white wine = &lt; 15 % alcohol content twice daily 3-4 week . ARM B : Patients receive oral non-wine nutritional supplement ( e.g. , Boost Ensure ) twice daily 3-4 week . After completion study treatment , patient follow every 6 month 2 year .</detailed_description>
	<criteria>Incurable , invasive malignancy Able reliably take study intervention prescribe protocol No prior current history alcoholism Alert mentally competent Physician estimate patient lose &gt; = 5 pound ( 2.3 kg ) weight = &lt; 2 month ( exclude perioperative weight loss ; document weight loss require ) and/or estimate caloric intake &lt; 20 cal/kg daily ( documentation necessary affirmative answer statement ) Patient perceive loss appetite and/or weight problem ; NOTE : Documentation necessary Concurrent chemotherapy and/or radiotherapy permit Negative pregnancy test do = &lt; 7 day prior registration , woman childbearing potential Willingness abstain completely alcohol 4 week , except prescribed trial ; NOTE : Patients assign nonwine nutritional supplement ( Arm B ) must willing abstain wine alcoholic beverage 34 week ; Patients assign white wine ( Arm A ) allow take nutritional supplement , Ensure Boost choose Ability complete questionnaire ( ) assistance Willingness return MCCRC enrol institution followup Patients use progestational agent anticipate permit study Shortterm use dexamethasone around day intravenous chemotherapy allow protection emesis , dexamethasone appetite stimulation permit Receiving tube feeding parenteral nutrition Current ( = &lt; 1 month ) plan treatment adrenal corticosteroid ( shortterm use dexamethasone around day chemotherapy allow protection emesis ) , androgens , progestational agent ; EXCEPTION : Inhalant , topical , optical steroid use permissible Progestational agent ( megestrol acetate ) plan initiate next 30 day ; NOTE : Patients megestrol acetate &gt; 1 month still otherwise meet eligibility criterion permit enroll protocol remain megestrol acetate Known mechanical obstruction alimentary tract , malabsorption , intractable vomiting ( &gt; 5 episodes/week ) Symptomatic untreated brain metastasis Any follow regimen may harmful develop fetus nursing child : pregnant woman , nurse woman , men woman childbearing potential unwilling employ adequate contraception</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
</DOC>